ep 34. r.s.v.

Oct 28

On this episode, sam-splains respiratory syncytial virus (R.S.V.). Let’s learn about the symptoms of r.s.v., how it’s transmitted, and how we can prevent it! We’ll also learn about two ongoing clinical trials that are exploring vaccinations for populations at high risk for severe RSV infection!

Sources:

RSV (Respiratory Syncytial Virus Infection (RSV). Center for Disease Control and Prevention. (2022). Link: https://www.cdc.gov/rsv/index.html
What is RSV? What are RSV Risks and Symptoms? Link: https://www.synagis.com/what-is-rsv.html
Advisory Committee on Immunization Practices (ACIP) meeting @ CDC - Respiratory Syncytial Virus (RSV) Vaccines for Older Adults and for Maternal/Pediatrics: https://www.cdc.gov/vaccines/acip/meetings/slides-2022-10-19-20.html
“Nirsevimab for the prevention of RSV in all infants”. Nirsevimab by AstraZeneca and Sanofi. ACIP Presentation slides - October 20, 2022. Link: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-10-19-20/02-RSV-Mat-Ped-Felter-508.pdf
“Safety and Efficacy of Bivalent RSV Prefusion F Vaccine in Adults >= 60 Years of Age”. RENOIR by Pfizer. ACIP Presentation slides - October 20, 2022. Link: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-10-19-20/03-RSV-Adults-Gurtma-508.pdf